Evidence map›Paper›PMID 36054249›Full record

ArticleJournal of computational chemistry2022

Predicting antibiotic resistance in complex protein targets using alchemical free energy methods.

Alice E Brankin, Philip W Fowler

Open access · hybridAbstract read
In one paragraph

Article in Journal of computational chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Predicting rifampicin resistance inERJ open research · 2025
    Article
  6. Prediction of pyrazinamide resistance inJAC-antimicrobial resistance · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alice E BrankinNuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.ORCID 0000-0002-5070-6525
Philip W FowlerNuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.ORCID 0000-0003-0912-4483
John Radcliffe Hospital · GB

Funding

CompBioMedEU H2020 Centre of Excellence ProjectNational Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial ResistanceNational Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)Oxford Medical Research Council Doctoral Training Partnership and the Nuffield Department of Clinical MedicineUK High-End Computing Consortium for Biomolecular Simulation EP/R029407/1Wellcome TrustWellcome Trust Core Award 203141/Z/16/Z
6 · The paper itself

Abstract

Drug resistant Mycobacterium tuberculosis, which mostly results from single nucleotide polymorphisms in antibiotic target genes, poses a major threat to tuberculosis treatment outcomes. Relative binding free energy (RBFE) calculations can rapidly predict the effects of mutations, but this approach has not been tested on large, complex proteins. We use RBFE calculations to predict the effects of M. tuberculosis RNA polymerase and DNA gyrase mutations on rifampicin and moxifloxacin susceptibility respectively. These mutations encompass a range of amino acid substitutions with known effects and include large steric perturbations and charged moieties. We find that moderate numbers (n = 3-15) of short RBFE calculations can predict resistance in cases where the mutation results in a large change in the binding free energy. We show that the method lacks discrimination in cases with either a small change in energy or that involve charged amino acids, and we investigate how these calculation errors may be decreased.

Indexed as

Mycobacterium tuberculosisTuberculosisDNA GyraseDrug Resistance, MicrobialHumansMoxifloxacinMutationDNA GyraseMoxifloxacinalchemical free energy methodsantibiotic resistancemolecular dynamicsrelative binding free energy calculationstuberculosis

Identifiers

PMID36054249
PMCPMC9545121
OpenAlexW4293237719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.